Health Condition 1: null- Blood Pressure more than 160/90 mmhg or patient having high risk symptoms like blurring of vision, stroke, loss of consciousness, vaginal bleeding Health Condition 2: O141- Severe pre-eclampsia
Conditions
Interventions
Intervention1: Oral Methyldopa 750mg: Methyldopa administration in the community
relative maternal hypertension on arrival at facility (defined as sBP less than 110 mmHg)
Intervention2: Intramuscular MgSO4: 10g MgSO4 intramuscular loading dose (Single dose Only)
Control Interventi
Sponsors
The University of British Columbia
Eligibility
Inclusion criteria
Inclusion criteria: All pregnant women permanent residents in selected clusters of Belgaum and Bagalkot district of Karnataka
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be combined maternal and or perinatal outcome (either maternal, fetal or neonatal death or severe morbidity for the mother or baby)Timepoint: During Antenatal, Delivery and Postnatal 42 day followup | — |
Secondary
| Measure | Time frame |
|---|---|
| Impact of the CLIP intervention on the delays around triage and transport.Timepoint: During Antenatal, Delivery and Postnatal 42 day followup | — |
Countries
India, Mozambique, Nigeria, Pakistan
Contacts
Public ContactDr M B Bellad
J N Medical College
Outcome results
None listed